Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Meghan Salgia"'
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 2, Pp 276-280 (2018)
This case represents the challenge and creativity necessary when treating patients with metastatic renal cell carcinoma who have been exposed to multiple lines of therapy. At present, treatment with immune checkpoint inhibition has stabilized and imp
Externí odkaz:
https://doaj.org/article/1b4721e2992c4e41850614e714e312b0
Autor:
Yash Dara, Sumanta K. Pal, Matthew Feng, Nicholas Salgia, Dhruv Prajapati, Nora Ruel, Meghan Salgia, Michael Nissanoff, Richard Harwood
Publikováno v:
Kidney Cancer. 4:103-109
BACKGROUND: Twitter has emerged as an important platform for conversation surrounding cancer-related topics. As use has proliferated, a better classification of physicians engaging in cancer discussions on Twitter is warranted. OBJECTIVES: To better
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d8ad31e0496452e8e542661937be6c0
https://doi.org/10.3233/kca-200083
https://doi.org/10.3233/kca-200083
Autor:
Leonidas D. Arvanitis, Meghan Salgia, Jon Chung, Sumanta K. Pal, Huiqing Wu, Nazli Dizman, Siraj M. Ali
Publikováno v:
Clinical Genitourinary Cancer. 18:e289-e292
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eac75feeb6c40d973e5f5985bda7ebe5
https://doi.org/10.1016/j.clgc.2019.11.020
https://doi.org/10.1016/j.clgc.2019.11.020
Publikováno v:
Nature Reviews Urology. 17:271-291
In the era of precision oncology, liquid biopsy techniques, especially the use of plasma circulating tumour DNA (ctDNA) analysis, represent a paradigm shift in the use of genomic biomarkers with considerable implications for clinical practice. Compar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f713a8ea552cf156bfabe1968add5d60
https://doi.org/10.1038/s41585-020-0297-9
https://doi.org/10.1038/s41585-020-0297-9
Autor:
Nora Ruel, Ishaan Seghal, Deborah A. Salgia, Sumanta K. Pal, Meghan Salgia, Nicholas Salgia, Ravi Salgia, Frank Bautista, Sabrina Salgia, Sweta Prajapati
Publikováno v:
Kidney cancer (Clifton, Va.)
OBJECTIVES: To better characterize the relay of information about prostate, kidney, and bladder cancer on Twitter in relation to the COVID-19 pandemic. MATERIALS AND METHODS: Tweets containing the joint hashtags “#COVID-19” and either “#bladder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93931936801289bacfec1cf9a52807c9
https://pubmed.ncbi.nlm.nih.gov/34368520
https://pubmed.ncbi.nlm.nih.gov/34368520
Autor:
Meghan Salgia, Lixin Yang, Ye Zhou, Bing Xu, Jeremy O. Jones, Yunchao Liu, Yan Wang, Jingbo Zhang, Rong Du, Fuwei Li, Mengjian Li
Publikováno v:
Molecular and Clinical Oncology
The genomic landscape of metastatic renal cell carcinoma (RCC) is not well understood, and currently available data suggest that it is functionally distinct from that of localized tumors. Additionally, the large number of approved and trial agents us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::200ae7ad25a0ce74378e2a975583ed39
https://doi.org/10.3892/mco.2020.2178
https://doi.org/10.3892/mco.2020.2178
Autor:
Paulo Gustavo Bergerot, Cristiane Decat Bergerot, William Dale, Kimlin Tam Ashing, Errol J. Philip, Sumanta K. Pal, Min Li, Nazli Dizman, Meghan Salgia, Maria Fernanda Marcusso Manhães, Renata Nunes Pedras, Edvane Birelo Lopes De Domenico
Publikováno v:
Psycho-Oncology. 27:2740-2746
OBJECTIVE Rare cancers are a heterogeneous group of conditions that can be associated with emotional and physical impairments. In view of the dearth of research in this area, we investigated the quality of life and prevalence of distress in a cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faa6e65ac9bf2c4df381ae177633ab35
https://doi.org/10.1002/pon.4873
https://doi.org/10.1002/pon.4873
Publikováno v:
Kidney Cancer
The treatment of metastatic renal cell carcinoma (mRCC) has evolved markedly over the past several decades; first with the introduction of targeted therapies and more recently with data supporting checkpoint inhibition. However, the vast majority of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eabcbd4ab92fa03fc8d5f6b75c69748
http://europepmc.org/articles/PMC6179117
http://europepmc.org/articles/PMC6179117
Publikováno v:
Urology Case Reports
Although the outcomes have improved in metastatic castrate-resistant prostate cancer (mCRPC), there is a limited arsenal of treatment options at the oncologist's disposal. The options range from enzalutamide and abiraterone (hormone-based therapies),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ab482d0efc7143638a339ce36f60711
http://europepmc.org/articles/PMC5991312
http://europepmc.org/articles/PMC5991312
Autor:
Sumanta K. Pal, Maya Otto-Duessel, Michael Lee, Meghan Salgia, Ben T. Copeland, David K. Ann, Catherine C. Elix, Christopher Yoo, Jeremy O. Jones, Ben Yi Tew
Publikováno v:
Prostate
Background Prostate cancer (PC) remains a leading cause of cancer mortality and the most successful chemopreventative and treatment strategies for PC come from targeting the androgen receptor (AR). Although AR plays a key role, it is likely that othe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67bc7e64a8eeadf86757d61a294a2675
https://europepmc.org/articles/PMC8985763/
https://europepmc.org/articles/PMC8985763/
